Capriglobal — Trading Ideas on TradingView

Breaking: Capricor Therapeutics, Inc. (CAPR) Spike Almost 400% The share price of Capricor Therapeutics, Inc. (CAPR) saw a noteworthy uptick of almost 400% in Wednesday's market session breaking out of a bullish flag pattern. The asset is gearing for a move to the $50 resistant amidst market condition. In another recent news, which could be the precursor to the recent surge, Capricor Therapeutics ( NASDAQ:CAPR ), said on Wednesday its cell therapy for a rare muscular disorder met the main goal of a late-stage study, reviving hopes for U.S. approval after a setback and sending its shares up more than four-fold. Shares of the San Diego-based company soared 328% to $27.25, on track to add about $955 million in market value, if gains hold. Financial Performance In 2024, Capricor Therapeutics's revenue was $22.27 million, a decrease of -11.55% compared to the previous year's $25.18 million. Losses were -$40.47 million, 81.6% more than in 2023. About CAPR Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD.

SWING IDEA - CAPRI GLOBAL CAPITAL Capri Global Capital , a prominent non-banking financial company (NBFC), is showing technical indicators that suggest a promising swing trading opportunity. Reasons are listed below : 200 Zone is a Strong Support Zone : The 200 level has been established as a strong support zone, providing a solid base for potential upward movement. Bullish Engulfing on Daily Timeframe : The formation of a bullish engulfing candle on the daily chart indicates strong buying pressure and suggests potential for further upward movement. Support at 50 EMA : The stock is finding support at the 50-day exponential moving average (EMA), reinforcing the bullish sentiment and providing a strong support level. 0.618 Fibonacci Support : The stock is finding support at the 0.618 Fibonacci retracement level, a key area where prices often bounce back, indicating potential for an upward move. Increase in Volumes : A noticeable increase in trading volumes confirms the strength of the price move and indicates growing investor interest. Target - 250 // 290 Stoploss - weekly close below 197 DISCLAIMER - Decisions to buy, sell, hold or trade in securities, commodities and other investments involve risk and are best made based on the advice of qualified financial professionals. Any trading in securities or other investments involves a risk of substantial losses. The practice of "Day Trading" involves particularly high risks and can cause you to lose substantial sums of money. Before undertaking any trading program, you should consult a qualified financial professional. Please consider carefully whether such trading is suitable for you in light of your financial condition and ability to bear financial risks. Under no circumstances shall we be liable for any loss or damage you or anyone else incurs as a result of any trading or investment activity that you or anyone else engages in based on any information or material you receive through TradingView or our services. @visionary.growth.insights

CCGL - Long view Once can buy CCGL - Capri Global Capital Ltd(consumer financials) above 780 for a price Target of 850++ with a Stop Loss of below 735. Above 805 the stock could give a breakout. The move may not be a huge move so would suggest booking your profits at the earliest. RSI at around 63 and the prices trading above all important EMA which could support the movement of the prices. Today the stock has moved up 2% with a volume of 2,01,946.00. CCGL is trading at a P/E ratio of 65 compared to the sector P/E ratio of 23. Right not the stock is trading inside the channel making higher highs and higher lows. Wait for break of channel to enter the trade. The views presented are of the author and do not represent a trade. Kindly consult your financial advisor before investing.